A citation-based method for searching scientific literature

M Moschetta, A George, S B Kaye, S Banerjee. Ann Oncol 2016
Times Cited: 95

Nicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, Aron C Eklund, Qiyuan Li, Ruiyang Tian, Christian Bowman-Colin, Yang Li, April Greene-Colozzi, J Dirk Iglehart, Nadine Tung, Paula D Ryan, Judy E Garber, Daniel P Silver, Zoltan Szallasi, Andrea L Richardson. Cancer Discov 2012
Times Cited: 249

List of shared articles

Times cited

Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer.
Jeffrey A How, Amir A Jazaeri, Bryan Fellman, Molly S Daniels, Suzanna Penn, Cara Solimeno, Ying Yuan, Kathleen Schmeler, Jerry S Lanchbury, Kirsten Timms,[...]. Cancers (Basel) 2021

Whence High-Grade Serous Ovarian Cancer.
Elise C Kohn, S Percy Ivy. Am Soc Clin Oncol Educ Book 2017

Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer.
Adriaan Vanderstichele, Pieter Busschaert, Siel Olbrecht, Diether Lambrechts, Ignace Vergote. Eur J Cancer 2017

Rucaparib in ovarian cancer: an update on safety, efficacy and place in therapy.
Graziela Z Dal Molin, Kohei Omatsu, Anil K Sood, Robert L Coleman. Ther Adv Med Oncol 2018

GSA: an independent development algorithm for calling copy number and detecting homologous recombination deficiency (HRD) from target capture sequencing.
Dongju Chen, Minghui Shao, Pei Meng, Chunli Wang, Qi Li, Yuhang Cai, Chengcheng Song, Xi Wang, Taiping Shi. BMC Bioinformatics 2021

Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy?
Rosalba Torrisi, Monica Zuradelli, Elisa Agostinetto, Giovanna Masci, Agnese Losurdo, Rita De Sanctis, Armando Santoro. Crit Rev Oncol Hematol 2019